FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170012142> ?p ?o ?g. }

• W2170012142 endingPage "1101" @default.
• W2170012142 startingPage "1091" @default.
• W2170012142 abstract "This study is a pharmacogenetic clinical trial designed to clarify whether the N-acetyltransferase 2 gene (NAT2) genotype-guided dosing of isoniazid improves the tolerability and efficacy of the 6-month four-drug standard regimen for newly diagnosed pulmonary tuberculosis. In a multicenter, parallel, randomized, and controlled trial with a PROBE design, patients were assigned to either conventional standard treatment (STD-treatment: approx. 5 mg/kg of isoniazid for all) or NAT2 genotype-guided treatment (PGx-treatment: approx. 7.5 mg/kg for patients homozygous for NAT2*4: rapid acetylators; 5 mg/kg, patients heterozygous for NAT2*4: intermediate acetylators; 2.5 mg/kg, patients without NAT2*4: slow acetylators). The primary outcome included incidences of 1) isoniazid-related liver injury (INH-DILI) during the first 8 weeks of therapy, and 2) early treatment failure as indicated by a persistent positive culture or no improvement in chest radiographs at the8th week. One hundred and seventy-two Japanese patients (slow acetylators, 9.3 %; rapid acetylators, 53.5 %) were enrolled in this trial. In the intention-to-treat (ITT) analysis, INH-DILI occurred in 78 % of the slow acetylators in the STD-treatment, while none of the slow acetylators in the PGx-treatment experienced either INH-DILI or early treatment failure. Among the rapid acetylators, early treatment failure was observed with a significantly lower incidence rate in the PGx-treatment than in the STD-treatment (15.0 % vs. 38 %). Thus, the NAT2 genotype-guided regimen resulted in much lower incidences of unfavorable events, INH-DILI or early treatment failure, than the conventional standard regimen. Our results clearly indicate a great potential of the NAT2 genotype-guided dosing stratification of isoniazid in chemotherapy for tuberculosis." @default.
• W2170012142 created "2016-06-24" @default.
• W2170012142 creator A5014423509 @default.
• W2170012142 creator A5029185764 @default.
• W2170012142 creator A5047229017 @default.
• W2170012142 creator A5050014937 @default.
• W2170012142 creator A5051368308 @default.
• W2170012142 creator A5053995372 @default.
• W2170012142 creator A5068202119 @default.
• W2170012142 creator A5074367560 @default.
• W2170012142 creator A5079112254 @default.
• W2170012142 creator A5084231732 @default.
• W2170012142 creator A5089702039 @default.
• W2170012142 date "2012-11-14" @default.
• W2170012142 modified "2023-10-16" @default.
• W2170012142 title "NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy" @default.
• W2170012142 cites W1966268063 @default.
• W2170012142 cites W1966268750 @default.
• W2170012142 cites W1970189825 @default.
• W2170012142 cites W1976344799 @default.
• W2170012142 cites W1984672882 @default.
• W2170012142 cites W1989219811 @default.
• W2170012142 cites W2011863437 @default.
• W2170012142 cites W2019883403 @default.
• W2170012142 cites W2035685562 @default.
• W2170012142 cites W2042333540 @default.
• W2170012142 cites W2044956533 @default.
• W2170012142 cites W2047966951 @default.
• W2170012142 cites W2060626299 @default.
• W2170012142 cites W2078363932 @default.
• W2170012142 cites W2090371903 @default.
• W2170012142 cites W2093714545 @default.
• W2170012142 cites W2095134596 @default.
• W2170012142 cites W2109028417 @default.
• W2170012142 cites W2116611451 @default.
• W2170012142 cites W2120343562 @default.
• W2170012142 cites W2124600282 @default.
• W2170012142 cites W2135355814 @default.
• W2170012142 cites W2418210342 @default.
• W2170012142 cites W37123703 @default.
• W2170012142 cites W4211002175 @default.
• W2170012142 doi "https://doi.org/10.1007/s00228-012-1429-9" @default.
• W2170012142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3641305" @default.
• W2170012142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23150149" @default.
• W2170012142 hasPublicationYear "2012" @default.
• W2170012142 type Work @default.
• W2170012142 sameAs 2170012142 @default.
• W2170012142 citedByCount "177" @default.
• W2170012142 countsByYear W21700121422013 @default.
• W2170012142 countsByYear W21700121422014 @default.
• W2170012142 countsByYear W21700121422015 @default.
• W2170012142 countsByYear W21700121422016 @default.
• W2170012142 countsByYear W21700121422017 @default.
• W2170012142 countsByYear W21700121422018 @default.
• W2170012142 countsByYear W21700121422019 @default.
• W2170012142 countsByYear W21700121422020 @default.
• W2170012142 countsByYear W21700121422021 @default.
• W2170012142 countsByYear W21700121422022 @default.
• W2170012142 countsByYear W21700121422023 @default.
• W2170012142 crossrefType "journal-article" @default.
• W2170012142 hasAuthorship W2170012142A5014423509 @default.
• W2170012142 hasAuthorship W2170012142A5029185764 @default.
• W2170012142 hasAuthorship W2170012142A5047229017 @default.
• W2170012142 hasAuthorship W2170012142A5050014937 @default.
• W2170012142 hasAuthorship W2170012142A5051368308 @default.
• W2170012142 hasAuthorship W2170012142A5053995372 @default.
• W2170012142 hasAuthorship W2170012142A5068202119 @default.
• W2170012142 hasAuthorship W2170012142A5074367560 @default.
• W2170012142 hasAuthorship W2170012142A5079112254 @default.
• W2170012142 hasAuthorship W2170012142A5084231732 @default.
• W2170012142 hasAuthorship W2170012142A5089702039 @default.
• W2170012142 hasBestOaLocation W21700121421 @default.
• W2170012142 hasConcept C104317684 @default.
• W2170012142 hasConcept C126322002 @default.
• W2170012142 hasConcept C135763542 @default.
• W2170012142 hasConcept C141071460 @default.
• W2170012142 hasConcept C142724271 @default.
• W2170012142 hasConcept C168563851 @default.
• W2170012142 hasConcept C197934379 @default.
• W2170012142 hasConcept C2776967927 @default.
• W2170012142 hasConcept C2778375690 @default.
• W2170012142 hasConcept C2781069245 @default.
• W2170012142 hasConcept C2781413609 @default.
• W2170012142 hasConcept C55493867 @default.
• W2170012142 hasConcept C55775858 @default.
• W2170012142 hasConcept C71924100 @default.
• W2170012142 hasConcept C86803240 @default.
• W2170012142 hasConcept C90924648 @default.
• W2170012142 hasConcept C98274493 @default.
• W2170012142 hasConceptScore W2170012142C104317684 @default.
• W2170012142 hasConceptScore W2170012142C126322002 @default.
• W2170012142 hasConceptScore W2170012142C135763542 @default.
• W2170012142 hasConceptScore W2170012142C141071460 @default.
• W2170012142 hasConceptScore W2170012142C142724271 @default.
• W2170012142 hasConceptScore W2170012142C168563851 @default.
• W2170012142 hasConceptScore W2170012142C197934379 @default.
• W2170012142 hasConceptScore W2170012142C2776967927 @default.
• W2170012142 hasConceptScore W2170012142C2778375690 @default.

• next